Effects of Gemcitabine on renal function in patients with non-small cell lung cancer

This publication has 9 references indexed in Scilit:

• Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
  European Journal of Cancer, 1996
• Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.
  Journal of Clinical Oncology, 1994
• Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.
  Journal of Clinical Oncology, 1994
• Gemcitabine: current status of phase I and II trials.
  Journal of Clinical Oncology, 1994
• Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days
  European Journal of Cancer, 1994
• Difluorodeoxycytidine (dFdC) — gemcitabine: A phase I study
  Investigational New Drugs, 1992
• A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
  Journal of Clinical Oncology, 1991
• Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer.
  Clinical Chemistry, 1986
• Radioimmunoassay of β₂-Microglobulin in Human Biological Fluids
  Scandinavian Journal of Clinical and Laboratory Investigation, 1971